CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis
NACompletedINTERVENTIONAL
Enrollment
174
Participants
Timeline
Start Date
April 30, 2006
Primary Completion Date
February 29, 2008
Study Completion Date
July 31, 2008
Conditions
Ulcerative Colitis
Interventions
DEVICE
Adacolumn®
Trial Locations (1)
60431
Markus-Krankenhaus, Frankfurt am Main
All Listed Sponsors
lead
Otsuka Frankfurt Research Institute GmbH
INDUSTRY
NCT00366925 - CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis | Biotech Hunter | Biotech Hunter